TEST BANK Applied Pharmacology for the Dental Hygienist 9/E Elena Haveles
Chapter 01: Information Sources, Regulatory Agencies, Drug Legislation, and
Prescription Writing
Haveles: Applied Pharmacology for the Dental Hygienist, 9th Edition
MULTIPLEwDCHOICE
1. KnowledgewDofwDpharmacologywDaidswDthewDdentalwDprofessionalwDin
a. obtainingwDawDpatient’swDhealthwDhistory.
b. administeringwDdrugswDinwDthewDoffice.
c. handlingwDemergencywDsituations.
d. selectionwDofwDawDnonprescriptionwDmedication.
e. AllwDofwDthewDabove.
ANS:w D E
AllwDofwDthewDchoiceswDarewDtrue.wDBecausewDmanywDofwDourwDpatientswDarewDbeingwDtreatedwDwithwDd
rugs,wDknowledgewDofwDpharmacologywDhelpswDinwDunderstandingwDandwDinterpretingwDpatients’wDre
sponseswDtowDhealthwDhistorywDquestions.wDKnowledgewDofwDthewDtherapeuticwDandwDadversewDeffect
swDofwDmedicationswDobviouslywDhelpswDinwDtheirwDproperwDadministrationwDinwDthewDoffice.wDEmerg
encywDsituationswDmaywDbewDcausedwDbywDdrugswDorwDtreatedwDbywDdrugs;wDthus,wDknowledgewDofwDp
harmacologywDiswDofwDgreatwDhelp,wDespeciallywDbecausewDawDrapidwDresponsewDiswDsometimeswDrequ
ired.wDAwDclearwDunderstandingwDofwDthewDconceptswDofwDdrugwDaction,wDdrugwDhandlingwDbywDthewDbo
dy,wDandwDdrugwDinteractionswDwillwDallowwDthewDdentalwDpractitionerwDtowDmakewDproperwDjudgment
swDandwDgraspwDthewDconceptswDrelevantwDtowDnewwDdrugwDtherapieswDonwDthewDmarket.
DIF: Application
REF:w D RolewDofwDthewDDentalwDHygienistwD(Medication/HealthwDHistory),wDRolewDofwDthewDDentalwDHyg
ienistwD(MedicationwDAdministration),wDRolewDofwDthewDDentalwDHygienistwD(EmergencywDSituations),wDRo
lewDofwDthewDDentalwDHygienistwD(NonprescriptionwDMedication)wD|wDpp.wD2-3 OBJ:w D 1
TOP:w D NBDHE,wD6.0.wDPharmacology
2. WhichwDofwDthewDfollowingwDstatementswDiswDtruewDregardingwDplanningwDappointments?
a. WhetherwDorwDnotwDpatientswDarewDtakingwDmedicationwDforwDsystemicwDdiseaseswDi
swDofwDlittlewDconsequencewDinwDthewDdentalwDoffice.
b. AsthmaticwDpatientswDshouldwDhavewDdentalwDappointmentswDinwDthewDmorning.
c. DiabeticwDpatientswDusuallywDhavewDfewerwDproblemswDwithwDawDmorningwDappo
intmentwDcomparedwDwithwDafternoonwDappointments.
d. BothwDBwDandwDCwDarewDtrue.
ANS:w D D
AsthmaticwDpatientswDwhowDexperiencewDdentalwDanxietywDshouldwDschedulewDtheirwDappointmentsw
DwhenwDtheywDarewDnot wDrushedwDorwDunderwDpressurewDearlywDinwDthewDmorning.wDDiabeticwDpatient
swDusuallywDhavewDrelativelywDfewerwDproblemswDwithwDawDmorningwDappointment.wDPatientswDtaki
ngwDmedicationwDforwDsystemicwDdiseaseswDmaywDrequirewDspecialwDhandlingwDinwDthewDdentalwDoffi
ce.
DIF: Comprehension
REF:w D RolewDofwDthewDDentalwDHygienistwD(AppointmentwDSchedulin
g)wD|wDp.wD3wDOBJ:w D 1 TOP:w D NBDHE,wD6.0.wDPharmacology
3. NutritionalwDorwDherbalwDsupplements
a. carrywDthewDU.S.wDFoodwDandwDDrugwDAdministrationwD(FDA)wDapprovalwDforwDdiseasewDstates.
, b. arewDnotwDdrugs.
c. canwDcausewDadversewDeffects.
d. willwDnotwDinteractwDwithwDotherwDdrugswDthewDpatientwDmaywDbewDtaking.
ANS:w D C
NutritionalwDorwDherbalwDsupplementswDarewDquitewDcapablewDofwDcausingwDadversewDeffects.wDThewD
majoritywDofwDnutritionalwDorwDherbalwDsupplementswDdowDnotwDcarrywDFDAwDapprovalwDforwDtreating
wDdiseasewDstates.wDThesewDsupplementswDarewDdrugs wDandwDcanwDcausewDadversewDeffects wDandwDinte
ractwDwithwDdifferentwDdrugs.
DIF: Comprehension
REF:w D RolewDofwDthewDDentalwDHygienistwD(NutritionalwDorwDHerbalwDSuppleme
nts)wD|wDp.wD3wDOBJ:w D 1 TOP:w D NBDHE,wD6.0.wDPharmacology
4. WhichwDtypewDofwDdrugwDnamewDusuallywDbeginswDwithwDawDlowercasewDletter?
a. BrandwDname
b. CodewDname
c. GenericwDname
d. TradewDname
ANS:w D C
BeforewDanywDdrugwDiswDmarketed,wDitwDiswDgivenwDawDgenericwDnamewDthatwDbecomeswDthewD―official
‖wDnamewDofwDthewDdrug.wDEachwDdrugwDiswDassignedwDonlywDonewDgenericwDnamewDselectedwDbywDthe
wDU.S.wDAdoptedwDNamewDCouncil,wDandwDthewDnamewDiswDnotwDcapitalized.wDThewDbrandwDnamewDis
wDequivalentwDtowDthewDtradewDnamewDandwDiswDcapitalized.wDAlthoughwDthewDbrandwDnamewDiswDtechn
icallywDthewDnamewDofwDthewDcompanywDmarketingwDthewDproduct,wDthiswDtermwDiswDoftenwDusedwDinte
rchangeablywDwithwDthewDtradewDname.wDThewDcodewDnamewDiswDthewDinitialwDtermwDusedwDwithinwDaw
Dpharmaceutical wDcompanywDtowDreferwDtowDawDdrugwDwhilewDitwDiswDundergoingwDinvestigationwDand
wDiswDoftenwDawDcombinationwDofwDcapitalwDletterswDandwDnumbers,wDthewDletterswDrepresentingwDanwDa
bbreviationwDofwDthewDcompanywDname.
DIF: Comprehension
REF:w D DrugwDNameswD|wDp.wD4wDOBJ:w D 3
TOP:w D NBDHE,wD6.0.wDPharmacology
5. AwDdrug’swDgenericwDnamewDiswDselectedwDbywDthe
a. pharmaceuticalwDcompanywDmanufacturingwDit.
b. FoodwDandwDDrugwDAdministrationwD(FDA).
c. U.S.wDAdoptedwDNamewDCouncil.
d. FederalwDPatentwDOffice.
ANS:w D C
EachwDdrugwDiswDassignedwDonlywDonewDgenericwDnamewD(e.g.,wDibuprofen).wDItwDiswDselectedwDbywDth
ewDU.S.wDAdoptedwDNamewDCouncil.wDThewDgenericwDnamewDiswDnotwDselectedwDbywDthewDFDAwDorwDt
hewDFederalwDPatentwDOffice.wDThewDpharmaceuticalwDcompanywDmanufacturingwDthewDdrugwDclearl
ywDhaswDanwDinfluencewDonwDthewDgenericwDnamewDgivenwDitswDdrug,wDbutwDthewDfinalwDdecisionwDiswDno
twDthewDcompany’s.
DIF: Recall REF:w D DrugwDNameswD|wDp.wD4
OBJ:w D 3wDTOP:w D NBDHE,wD6.0.wDPharmacology
6. WhichwDofwDthewDfollowingwDiswDtruewDconcerningwDgenericwDandwDtradewDnameswDofwDdrugs?
a. AwDdrugwDmaywDonlywDhavewDonewDgenericwDnamewDandwDonewDtradewDname.
b. AwDdrugwDmaywDonlywDhavewDonewDgenericwDname,wDbutwDitwDmaywDhavewDseveralwDtradewDnames.
c. AwDdrugwDmaywDhavewDseveralwDgenericwDnames,wDbutwDitwDmaywDonlywDhavewDonewDtradewDname.
d. AwDdrugwDmaywDhavewDseveralwDgenericwDnameswDandwDseveralwDtradewDnames.
, ANS:w D B
EachwDdrugwDhaswDonlywDonewDgenericwDnamewDbutwDmaywDhavewDseveralwDtradewDnames.wDForwDeach
wDdrug,wDtherewDiswDonlywDonewDgenericwDname.wDIt wDiswDnotwDcapitalized, wDandwDitwDbecomeswDthewD―o
fficial‖wDnamewDofwDthewDdrug.wDThewDpharmaceuticalwDcompanywDdiscoveringwDthewDdrugwDgiveswDt
hewDdrugwDawDtradewDname.wDThewDtradewDnamewDiswDprotectedwDbywDthewDFederalwDPatentwDLawwDforwD
20wDyearswDfromwDthewDearliestwDclaimedwDfilingwDdate,wDpluswDpatentwDtermwDextensions.wDAlthoughw
DthewDbrandwDnamewDiswDtechnicallywDthewDnamewDofwDthewDcompanywDmarketingwDthewDproduct, wDitwD
iswDoftenwDusedwDinterchangeablywDwithwDthewDtradewDname.
DIF: Comprehension
REF:w D DrugwDNameswD|wDp.wD4wDOBJ:w D 3
TOP:w D NBDHE,wD6.0.wDPharmacology
7. TwowDdrugswDthatwDarewDfoundwDtowDbewDchemicallywDequivalent,wDbutwDnotwDbiologicallywDeq
uivalentwDorwDtherapeuticallywDequivalentwDarewDsaidwDtowDdifferwDin
a. potency.
b. efficacy.
c. bioavailability.
d. therapeuticwDindex.
ANS:w D C
AwDpreparationwDcanwDbewDchemicallywDequivalentwDyetwDnotwDbiologicallywDorwDtherapeuticallywDeq
uivalent.wDThesewDproductswDarewDsaidwDtowDdifferwDinwDtheirwDbioavailability.wDThewDpotencywDofwDawD
drugwDiswDawDfunctionwDofwDthewDamountwDofwDdrugwDrequiredwDtowDproducewDanwDeffect.wDThewDeffica
cywDiswDthewDmaximumwDintensitywDofwDeffectwDorwDresponsewDthatwDcanwDbewDproducedwDbywDawDdrug
.wDThewDtherapeuticwDindexwDiswDthewDratiowDofwDthewDlethalwDdosewDforwD50%wDofwDthewDexperimental
wDanimalswDdividedwDbywDthewDeffectivewDdosewDforwD50%wDofwDthewDexperimentalwDanimals. wDIfwDthe
wDvaluewDofwDthewDtherapeuticwDindexwDiswDsmall,wDtoxicitywDiswDmorewDlikely.
DIF: Recall
REF:w D DrugwDNameswD(DrugwDSubstitution)wD|wDp.wD5wDOBJ:
w D 4 TOP:w D NBDHE,wD6.0.wDPharmacology
8. HowwDmanywDyearswDmustwDpasswDafterwDawDdrugwDpatentwDexpireswDbeforewDotherwDdrugwDcom
panieswDcanwDmarketwDthewDsamewDcompoundwDaswDawDgenericwDdrug?
a. 20wDyears
b. 17wDyears
c. 7wDyears
d. 0wDyears
ANS:w D D
OncewDawDdrugwDpatentwDexpires,wDcompetingwDcompanieswDmaywDimmediatelywDmarketwDthewDsam
ewDcompoundwDinwDgenericwDform.wDThewDpharmaceuticalwDcompanywDdiscoveringwDthewDdrugwDgiv
eswDthewDdrugwDawDtradewDname.wDThewDtradewDnamewDiswDprotectedwDbywDthewDFederalwDPatentwDLaw
wDforwD20wD yearswDfrom wDthewDearliestwDclaimedwDfilingwDdate,wDplus wDthewDpatent wDtermwDextensions
.
DIF: Application
REF:w D DrugwDNameswD(DrugwDSubstitution)wD|wDp.wD5wDOBJ:
w D 4 TOP:w D NBDHE,wD6.0.wDPharmacology
9. TwowDdrugwDformulationswDthatwDproducewDsimilarwDconcentrationswDinwDthewDbloodwDandwDtissueswD
afterwDdrugwDadministrationwDarewDtermedwD equivalent.
a. chemically
b. biologically
, c. therapeutically
Chapter 01: Information Sources, Regulatory Agencies, Drug Legislation, and
Prescription Writing
Haveles: Applied Pharmacology for the Dental Hygienist, 9th Edition
MULTIPLEwDCHOICE
1. KnowledgewDofwDpharmacologywDaidswDthewDdentalwDprofessionalwDin
a. obtainingwDawDpatient’swDhealthwDhistory.
b. administeringwDdrugswDinwDthewDoffice.
c. handlingwDemergencywDsituations.
d. selectionwDofwDawDnonprescriptionwDmedication.
e. AllwDofwDthewDabove.
ANS:w D E
AllwDofwDthewDchoiceswDarewDtrue.wDBecausewDmanywDofwDourwDpatientswDarewDbeingwDtreatedwDwithwDd
rugs,wDknowledgewDofwDpharmacologywDhelpswDinwDunderstandingwDandwDinterpretingwDpatients’wDre
sponseswDtowDhealthwDhistorywDquestions.wDKnowledgewDofwDthewDtherapeuticwDandwDadversewDeffect
swDofwDmedicationswDobviouslywDhelpswDinwDtheirwDproperwDadministrationwDinwDthewDoffice.wDEmerg
encywDsituationswDmaywDbewDcausedwDbywDdrugswDorwDtreatedwDbywDdrugs;wDthus,wDknowledgewDofwDp
harmacologywDiswDofwDgreatwDhelp,wDespeciallywDbecausewDawDrapidwDresponsewDiswDsometimeswDrequ
ired.wDAwDclearwDunderstandingwDofwDthewDconceptswDofwDdrugwDaction,wDdrugwDhandlingwDbywDthewDbo
dy,wDandwDdrugwDinteractionswDwillwDallowwDthewDdentalwDpractitionerwDtowDmakewDproperwDjudgment
swDandwDgraspwDthewDconceptswDrelevantwDtowDnewwDdrugwDtherapieswDonwDthewDmarket.
DIF: Application
REF:w D RolewDofwDthewDDentalwDHygienistwD(Medication/HealthwDHistory),wDRolewDofwDthewDDentalwDHyg
ienistwD(MedicationwDAdministration),wDRolewDofwDthewDDentalwDHygienistwD(EmergencywDSituations),wDRo
lewDofwDthewDDentalwDHygienistwD(NonprescriptionwDMedication)wD|wDpp.wD2-3 OBJ:w D 1
TOP:w D NBDHE,wD6.0.wDPharmacology
2. WhichwDofwDthewDfollowingwDstatementswDiswDtruewDregardingwDplanningwDappointments?
a. WhetherwDorwDnotwDpatientswDarewDtakingwDmedicationwDforwDsystemicwDdiseaseswDi
swDofwDlittlewDconsequencewDinwDthewDdentalwDoffice.
b. AsthmaticwDpatientswDshouldwDhavewDdentalwDappointmentswDinwDthewDmorning.
c. DiabeticwDpatientswDusuallywDhavewDfewerwDproblemswDwithwDawDmorningwDappo
intmentwDcomparedwDwithwDafternoonwDappointments.
d. BothwDBwDandwDCwDarewDtrue.
ANS:w D D
AsthmaticwDpatientswDwhowDexperiencewDdentalwDanxietywDshouldwDschedulewDtheirwDappointmentsw
DwhenwDtheywDarewDnot wDrushedwDorwDunderwDpressurewDearlywDinwDthewDmorning.wDDiabeticwDpatient
swDusuallywDhavewDrelativelywDfewerwDproblemswDwithwDawDmorningwDappointment.wDPatientswDtaki
ngwDmedicationwDforwDsystemicwDdiseaseswDmaywDrequirewDspecialwDhandlingwDinwDthewDdentalwDoffi
ce.
DIF: Comprehension
REF:w D RolewDofwDthewDDentalwDHygienistwD(AppointmentwDSchedulin
g)wD|wDp.wD3wDOBJ:w D 1 TOP:w D NBDHE,wD6.0.wDPharmacology
3. NutritionalwDorwDherbalwDsupplements
a. carrywDthewDU.S.wDFoodwDandwDDrugwDAdministrationwD(FDA)wDapprovalwDforwDdiseasewDstates.
, b. arewDnotwDdrugs.
c. canwDcausewDadversewDeffects.
d. willwDnotwDinteractwDwithwDotherwDdrugswDthewDpatientwDmaywDbewDtaking.
ANS:w D C
NutritionalwDorwDherbalwDsupplementswDarewDquitewDcapablewDofwDcausingwDadversewDeffects.wDThewD
majoritywDofwDnutritionalwDorwDherbalwDsupplementswDdowDnotwDcarrywDFDAwDapprovalwDforwDtreating
wDdiseasewDstates.wDThesewDsupplementswDarewDdrugs wDandwDcanwDcausewDadversewDeffects wDandwDinte
ractwDwithwDdifferentwDdrugs.
DIF: Comprehension
REF:w D RolewDofwDthewDDentalwDHygienistwD(NutritionalwDorwDHerbalwDSuppleme
nts)wD|wDp.wD3wDOBJ:w D 1 TOP:w D NBDHE,wD6.0.wDPharmacology
4. WhichwDtypewDofwDdrugwDnamewDusuallywDbeginswDwithwDawDlowercasewDletter?
a. BrandwDname
b. CodewDname
c. GenericwDname
d. TradewDname
ANS:w D C
BeforewDanywDdrugwDiswDmarketed,wDitwDiswDgivenwDawDgenericwDnamewDthatwDbecomeswDthewD―official
‖wDnamewDofwDthewDdrug.wDEachwDdrugwDiswDassignedwDonlywDonewDgenericwDnamewDselectedwDbywDthe
wDU.S.wDAdoptedwDNamewDCouncil,wDandwDthewDnamewDiswDnotwDcapitalized.wDThewDbrandwDnamewDis
wDequivalentwDtowDthewDtradewDnamewDandwDiswDcapitalized.wDAlthoughwDthewDbrandwDnamewDiswDtechn
icallywDthewDnamewDofwDthewDcompanywDmarketingwDthewDproduct,wDthiswDtermwDiswDoftenwDusedwDinte
rchangeablywDwithwDthewDtradewDname.wDThewDcodewDnamewDiswDthewDinitialwDtermwDusedwDwithinwDaw
Dpharmaceutical wDcompanywDtowDreferwDtowDawDdrugwDwhilewDitwDiswDundergoingwDinvestigationwDand
wDiswDoftenwDawDcombinationwDofwDcapitalwDletterswDandwDnumbers,wDthewDletterswDrepresentingwDanwDa
bbreviationwDofwDthewDcompanywDname.
DIF: Comprehension
REF:w D DrugwDNameswD|wDp.wD4wDOBJ:w D 3
TOP:w D NBDHE,wD6.0.wDPharmacology
5. AwDdrug’swDgenericwDnamewDiswDselectedwDbywDthe
a. pharmaceuticalwDcompanywDmanufacturingwDit.
b. FoodwDandwDDrugwDAdministrationwD(FDA).
c. U.S.wDAdoptedwDNamewDCouncil.
d. FederalwDPatentwDOffice.
ANS:w D C
EachwDdrugwDiswDassignedwDonlywDonewDgenericwDnamewD(e.g.,wDibuprofen).wDItwDiswDselectedwDbywDth
ewDU.S.wDAdoptedwDNamewDCouncil.wDThewDgenericwDnamewDiswDnotwDselectedwDbywDthewDFDAwDorwDt
hewDFederalwDPatentwDOffice.wDThewDpharmaceuticalwDcompanywDmanufacturingwDthewDdrugwDclearl
ywDhaswDanwDinfluencewDonwDthewDgenericwDnamewDgivenwDitswDdrug,wDbutwDthewDfinalwDdecisionwDiswDno
twDthewDcompany’s.
DIF: Recall REF:w D DrugwDNameswD|wDp.wD4
OBJ:w D 3wDTOP:w D NBDHE,wD6.0.wDPharmacology
6. WhichwDofwDthewDfollowingwDiswDtruewDconcerningwDgenericwDandwDtradewDnameswDofwDdrugs?
a. AwDdrugwDmaywDonlywDhavewDonewDgenericwDnamewDandwDonewDtradewDname.
b. AwDdrugwDmaywDonlywDhavewDonewDgenericwDname,wDbutwDitwDmaywDhavewDseveralwDtradewDnames.
c. AwDdrugwDmaywDhavewDseveralwDgenericwDnames,wDbutwDitwDmaywDonlywDhavewDonewDtradewDname.
d. AwDdrugwDmaywDhavewDseveralwDgenericwDnameswDandwDseveralwDtradewDnames.
, ANS:w D B
EachwDdrugwDhaswDonlywDonewDgenericwDnamewDbutwDmaywDhavewDseveralwDtradewDnames.wDForwDeach
wDdrug,wDtherewDiswDonlywDonewDgenericwDname.wDIt wDiswDnotwDcapitalized, wDandwDitwDbecomeswDthewD―o
fficial‖wDnamewDofwDthewDdrug.wDThewDpharmaceuticalwDcompanywDdiscoveringwDthewDdrugwDgiveswDt
hewDdrugwDawDtradewDname.wDThewDtradewDnamewDiswDprotectedwDbywDthewDFederalwDPatentwDLawwDforwD
20wDyearswDfromwDthewDearliestwDclaimedwDfilingwDdate,wDpluswDpatentwDtermwDextensions.wDAlthoughw
DthewDbrandwDnamewDiswDtechnicallywDthewDnamewDofwDthewDcompanywDmarketingwDthewDproduct, wDitwD
iswDoftenwDusedwDinterchangeablywDwithwDthewDtradewDname.
DIF: Comprehension
REF:w D DrugwDNameswD|wDp.wD4wDOBJ:w D 3
TOP:w D NBDHE,wD6.0.wDPharmacology
7. TwowDdrugswDthatwDarewDfoundwDtowDbewDchemicallywDequivalent,wDbutwDnotwDbiologicallywDeq
uivalentwDorwDtherapeuticallywDequivalentwDarewDsaidwDtowDdifferwDin
a. potency.
b. efficacy.
c. bioavailability.
d. therapeuticwDindex.
ANS:w D C
AwDpreparationwDcanwDbewDchemicallywDequivalentwDyetwDnotwDbiologicallywDorwDtherapeuticallywDeq
uivalent.wDThesewDproductswDarewDsaidwDtowDdifferwDinwDtheirwDbioavailability.wDThewDpotencywDofwDawD
drugwDiswDawDfunctionwDofwDthewDamountwDofwDdrugwDrequiredwDtowDproducewDanwDeffect.wDThewDeffica
cywDiswDthewDmaximumwDintensitywDofwDeffectwDorwDresponsewDthatwDcanwDbewDproducedwDbywDawDdrug
.wDThewDtherapeuticwDindexwDiswDthewDratiowDofwDthewDlethalwDdosewDforwD50%wDofwDthewDexperimental
wDanimalswDdividedwDbywDthewDeffectivewDdosewDforwD50%wDofwDthewDexperimentalwDanimals. wDIfwDthe
wDvaluewDofwDthewDtherapeuticwDindexwDiswDsmall,wDtoxicitywDiswDmorewDlikely.
DIF: Recall
REF:w D DrugwDNameswD(DrugwDSubstitution)wD|wDp.wD5wDOBJ:
w D 4 TOP:w D NBDHE,wD6.0.wDPharmacology
8. HowwDmanywDyearswDmustwDpasswDafterwDawDdrugwDpatentwDexpireswDbeforewDotherwDdrugwDcom
panieswDcanwDmarketwDthewDsamewDcompoundwDaswDawDgenericwDdrug?
a. 20wDyears
b. 17wDyears
c. 7wDyears
d. 0wDyears
ANS:w D D
OncewDawDdrugwDpatentwDexpires,wDcompetingwDcompanieswDmaywDimmediatelywDmarketwDthewDsam
ewDcompoundwDinwDgenericwDform.wDThewDpharmaceuticalwDcompanywDdiscoveringwDthewDdrugwDgiv
eswDthewDdrugwDawDtradewDname.wDThewDtradewDnamewDiswDprotectedwDbywDthewDFederalwDPatentwDLaw
wDforwD20wD yearswDfrom wDthewDearliestwDclaimedwDfilingwDdate,wDplus wDthewDpatent wDtermwDextensions
.
DIF: Application
REF:w D DrugwDNameswD(DrugwDSubstitution)wD|wDp.wD5wDOBJ:
w D 4 TOP:w D NBDHE,wD6.0.wDPharmacology
9. TwowDdrugwDformulationswDthatwDproducewDsimilarwDconcentrationswDinwDthewDbloodwDandwDtissueswD
afterwDdrugwDadministrationwDarewDtermedwD equivalent.
a. chemically
b. biologically
, c. therapeutically
